Localization Strengthens the Position of Russian Manufacturers in Medtech

The mobile assistive technology segment continues to grow at double-digit rates. According to Kommersant, citing research by TeDo, the market volume will approach 143 billion rubles by 2025 and exceed 311 billion rubles by 2030. The segment’s main products are lower limb prosthetics, orthopedic devices, and wheelchairs.

Evgeny Borisov, a partner at KAMA FLOW, explained to Kommersant that the position of Russian companies is being strengthened through localization.

“Currently, about 45–50% of products include proprietary components and Russian-developed solutions. Localization has become a key growth driver: domestic players are gaining ground. For instance, Motorica holds about 45% of the bionic hand prosthesis segment, Steplife has 20–25% of the bionic leg prosthesis market, and the CITTO and MPO Metallist group manufactures up to 70,000 products annually. Altogether, these companies account for about 60% of the value in the high-tech segment.”

Equally important, according to him, are state support and demand:

“Funding for advanced models, expanding the list of products available through certificates, and an import substitution policy all help to ease the burden on the budget and stimulate domestic manufacturing. Finally, there is growing demand: patients are increasingly choosing modern solutions and are willing to pay for quality and technology, which is shaping a market not only for social welfare, but also for innovative products.”



Read the article at the link.